Twist Bioscience Corporation (TWST)
NASDAQ: TWST · Real-Time Price · USD
49.24
+2.14 (4.54%)
At close: Feb 6, 2026, 4:00 PM EST
48.71
-0.53 (-1.08%)
After-hours: Feb 6, 2026, 7:59 PM EST
Twist Bioscience Stock Forecast
Stock Price Forecast
The 9 analysts that cover Twist Bioscience stock have a consensus rating of "Buy" and an average price target of $50.22, which forecasts a 1.99% increase in the stock price over the next year. The lowest target is $33 and the highest is $79.
Price Target: $50.22 (+1.99%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Twist Bioscience stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 2 | 3 | 3 |
| Buy | 5 | 5 | 6 | 5 | 5 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 2 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 9 | 10 | 8 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $42 → $52 | Buy | Maintains | $42 → $52 | +5.61% | Feb 3, 2026 |
| Barclays | Barclays | Buy Maintains $39 → $50 | Buy | Maintains | $39 → $50 | +1.54% | Feb 3, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $77 → $79 | Strong Buy | Maintains | $77 → $79 | +60.44% | Jan 26, 2026 |
| TD Cowen | TD Cowen | Strong Buy Maintains $32 → $43 | Strong Buy | Maintains | $32 → $43 | -12.67% | Jan 8, 2026 |
| Barclays | Barclays | Buy Maintains $37 → $39 | Buy | Maintains | $37 → $39 | -20.80% | Dec 15, 2025 |
Financial Forecast
Revenue This Year
439.72M
from 376.57M
Increased by 16.77%
Revenue Next Year
505.95M
from 439.72M
Increased by 15.06%
EPS This Year
-1.61
from -1.30
EPS Next Year
-1.17
from -1.61
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 455.1M | 529.2M | |||
| Avg | 439.7M | 506.0M | |||
| Low | 420.3M | 476.1M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 20.8% | 20.3% | |||
| Avg | 16.8% | 15.1% | |||
| Low | 11.6% | 8.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.07 | -0.67 | |
| Avg | -1.61 | -1.17 | |
| Low | -2.42 | -2.01 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.